Kimberly Westrich
Kimberly Westrich is the vice president for health services research for the National Pharmaceutical Council (NPC). Ms. Westrich has been with NPC since 2000 and is responsible for leading research initiatives on the value of pharmaceuticals. She has published extensively on issues related to value assessment frameworks, accountable care organizations, clinical pathways, risk-sharing agreements, quality performance measurement, comparative effectiveness research for health care decision-making, and value-based insurance design. Prior to joining NPC, Ms. Westrich served as director of research at the Pharmaceutical Research and Manufacturers of America (PhRMA). She also worked as a health care consultant at the Lewin Group …
Kimberly Westrich is the vice president for health services research for the National Pharmaceutical Council (NPC). Ms. Westrich has been with NPC since 2000 and is responsible for leading research initiatives on the value of pharmaceuticals. She has published extensively on issues related to value assessment frameworks, accountable care organizations, clinical pathways, risk-sharing agreements, quality performance measurement, comparative effectiveness research for health care decision-making, and value-based insurance design.
Prior to joining NPC, Ms. Westrich served as director of research at the Pharmaceutical Research and Manufacturers of America (PhRMA). She also worked as a health care consultant at the Lewin Group and as a pharmacoeconomic analyst at Johnson & Johnson.
Ms. Westrich received her master’s degree in economics from Northwestern University and undergraduate degree in economics from the College of William and Mary.
See more
Prior to joining NPC, Ms. Westrich served as director of research at the Pharmaceutical Research and Manufacturers of America (PhRMA). She also worked as a health care consultant at the Lewin Group and as a pharmacoeconomic analyst at Johnson & Johnson.
Ms. Westrich received her master’s degree in economics from Northwestern University and undergraduate degree in economics from the College of William and Mary.
Articles: Kimberly Westrich
Accumulating Barriers to Care: Double Jeopardy for US Patients
USA / Dan Leonard, Kimberly Westrich, and Brian Sils of the National Pharmaceutical Council examine how a new HHS ruling on how US patients pay for medicines could hurt them financially, exacerbating what is already a challenging time in the midst of the COVID-19 pandemic. The pandemic has been a challenging time for patients, many of…
Latest Report
